Cigna Corp. (CI) Tops Q3 EPS by 28c; offers guidance
Tweet
Share
E-mail
Get Alerts CI Hot Sheet
Price: $282.52 -1.31%
Revenue Growth %: +4.2%
Financial Fact:
Mail order pharmacy revenues: 762M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Revenue Growth %: +4.2%
Financial Fact:
Mail order pharmacy revenues: 762M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Cigna Corp. (NYSE: CI) reported Q3 EPS of $7.51, $0.28 better than the analyst estimate of $7.23. Revenue for the quarter came in at $63.7 billion versus the consensus estimate of $59.64 billion.
GUIDANCE:
Cigna Corp. sees FY2024 EPS of $28.40, versus the consensus of $28.50.
For earnings history and earnings-related data on Cigna Corp. (CI) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Concurrent Technologies (CNC:LN) PT Raised to GBP3.20 at Berenberg
- UBS Upgrades E.ON SE (EOAN:GR) (EONGY) to Buy
- JPMorgan Starts Bytes Technology Group PLC (BYIT:LN) at Underweight
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
